Striatal dopaminergic function in restless legs syndrome
暂无分享,去创建一个
D J Brooks | D. Brooks | D. Brooks | N. Turjanski | A J Lees | N Turjanski | A. Lees
[1] C D Marsden,et al. Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.
[2] C Trenkwalder,et al. Cerebral generators involved in the pathogenesis of the restless legs syndrome , 1997, Annals of neurology.
[3] R. Myers,et al. Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomography , 1992, Synapse.
[4] W. Gibb,et al. The restless legs syndrome. , 1986, Postgraduate medical journal.
[5] S. Chokroverty,et al. Review and videotape recognition of idiopathic restless legs syndrome , 1991, Movement disorders : official journal of the Movement Disorder Society.
[6] A. Malhotra,et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[8] D. Brooks,et al. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study. , 1995, Brain : a journal of neurology.
[9] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] S. O’Keeffe,et al. Iron status and restless legs syndrome in the elderly. , 1994, Age and ageing.
[11] C. Prasad,et al. REM sleep deprivation alters dopamine D2 receptor binding in the rat frontal cortex , 1995, Pharmacology Biochemistry and Behavior.
[12] J. Jankovic,et al. Restless legs syndrome , 1996, Neurology.
[13] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[14] Y. Agid,et al. Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology , 1994, Movement disorders : official journal of the Movement Disorder Society.
[15] D. J. Brooks,et al. In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson's disease patients with and without dyskinesias , 1997, Neurology.
[16] R. Godbout,et al. Treatment of restless legs syndrome and periodic movements during sleep with , 1988, Neurology.
[17] G. Lavigne,et al. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. , 1994, Sleep.
[18] Christopher Earley,et al. Toward a better definition of the restless legs syndrome , 1995, Movement disorders : official journal of the Movement Disorder Society.
[19] C. Trenkwalder,et al. Reflex studies and MRI in the restless legs syndrome , 1996, Acta neurologica Scandinavica.
[20] C D Marsden,et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. , 1990, Brain : a journal of neurology.
[21] M. Gilardi,et al. Physical performance of the latest generation of commercial positron scanner , 1988 .
[22] R. Godbout,et al. Familial restless legs with periodic movements in sleep , 1985, Neurology.
[23] R. Roth,et al. Pharmacology of mesocortical dopamine neurons. , 1983, Pharmacological reviews.